Nara, Japan

Tetsuo Kikuchi

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Axikin Pharmaceuticals, Inc.. Active years: 2010-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tetsuo Kikuchi. Retrieved from https://idiyas.com/inventor/tetsuo-kikuchi-g7on41z2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tetsuo Kikuchi: A Trailblazer in Innovation

Introduction:

Tetsuo Kikuchi, a renowned inventor hailing from Nara-ken, JP, is a visionary in the field of innovation. With a remarkable track record of two patents, he has significantly impacted the realm of pharmaceutical preparations.

Latest Patents:

Kikuchi's latest patents revolve around arylsulfonamide derivatives designed to function as CCR3 antagonists, catering to the treatment of inflammatory and immunological disorders. These derivatives exhibit potent CCR3 antagonistic activity, making them invaluable in combating diseases such as asthma, atopic dermatitis, and allergic rhinitis.

Career Highlights:

Having contributed immensely to the field of pharmaceuticals, Tetsuo Kikuchi currently serves at Axikin Pharmaceuticals, Inc. His expertise and dedication have played a pivotal role in advancing the development of novel treatments for various medical conditions.

Collaborations:

Collaborating with esteemed colleagues like Yingfu Li and Akihiko Watanabe, Kikuchi has fostered a culture of innovation and excellence. Through synergistic teamwork, they have pushed the boundaries of pharmaceutical research and development.

Conclusion:

In conclusion, Tetsuo Kikuchi stands as a true pioneer in the world of innovation, with a legacy that will continue to shape the future of technology for years to come. His contributions to the field of pharmaceuticals underscore his commitment to improving patient outcomes and advancing healthcare solutions for a better tomorrow.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…